banner https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4

Key highlights from Pfizer’s (PFE) Q1 2025 earnings results

Pfizer Inc. (NYSE: PFE) reported its first quarter 2025 earnings results today. Revenues decreased 8% year-over-year to $13.7 billion. GAAP net income decreased 5% to $2.96 billion, or $0.52 per share, compared to last year. Adjusted EPS increased 12% to $0.92. For full-year 2025, the company expects revenues of $61-64 billion and adjusted EPS of … Read more

PFE Earnings: Key quarterly highlights from Pfizer’s Q4 2024 financial results

Pfizer Inc. (NYSE: PFE) reported its fourth quarter 2024 earnings results today. Revenues increased 22% year-over-year to $17.8 billion. GAAP net income was $410 million, or $0.07 per share, compared to a loss of $3.37 billion, or $0.60 per share, last year. Adjusted EPS was $0.63. For fiscal year 2025, the company expects revenues of … Read more

banner banner https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4